Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 6250 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

Medical Sciences Division Academic Lead for Patient Involvement and Public Engagement

June 2025 - Volunteer opportunities

New international standard for monitoring the immunosuppressed defined in global study led by Oxford researchers

A major international study led by the Nuffield Department of Primary Care Health Sciences has developed a new, globally agreed approach to identifying and monitoring immunosuppressed adults at risk of severe COVID-19 illness.

The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences researchers deliver pioneering treatment for rare genetic condition

A team at NDORMS, University of Oxford has successfully administered a pioneering treatment to a patient with XIAP deficiency, a rare genetic disorder.

University of Oxford announces new Professorship and Centre for Global Primary Care, with support from Dr Sadok Besrour

Nuffield Department of Primary Care Health Sciences, University of Oxford will expand its work in global primary care with a new centre and professorship, thanks to a generous £8.4 million gift from the Fondation Docteur Sadok Besrour.

Bodleian Libraries Update - May 2025 - Bodleian Blog | Requests | NIH Funding Policy

T cell responses to monkeypox play a part in protecting against infection

A new study, led by researchers at the CAMS Oxford Institute in the Nuffield Department of Medicine and TIDU in the MRC Weatherall Institute of Molecular Medicine, has found that specific T cells could have an impact on the long-term protective responses to future infection.

More effective and affordable treatment strategies for Hepatitis C

Oxford University Clinical Research Unit (OUCRU) announced promising results from the VIETNARMS trial, a years-long multi-arm clinical trial conducted in Vietnam. The trial found that the readily available and affordable Hepatitis C treatment sofosbuvir/daclatasvir had a >95% cure rate. The results offer important insights into new treatment regimens for Hepatitis C, potentially reducing treatment durations and halving treatment costs.

Beyond the Ivory Tower event: Participants explore what it means to decolonise global health

Green Templeton College recently hosted a powerful event, building on the Nuffield Department of Primary Care Health Sciences 12-part 'Decolonising Global Health' blog series. The event brought together voices from the Global South to share their experiences, challenge entrenched power dynamics and explore practical strategies for creating more equitable health systems.

MBRRACE-UK report shows rate of stillbirths and neonatal deaths decreased in 2023 but persistent inequalities remain

The MBRRACE-UK collaboration, jointly led by Oxford Population Health’s National Perinatal Epidemiology Unit and the University of Leicester’s TIMMS research group, has today published a ‘State of the Nation’ report on perinatal deaths of babies born in the UK in 2023.

Study identifies key immune structures in the gut that may drive coeliac disease

Researchers in Oxford have found structures of immune cells in the gut that may be driving the response to gluten in people with coeliac disease and could provide a target for future therapies.

First participant recruited to pioneering UK trial in global effort to tackle early causes of Parkinson’s

A pioneering clinical trial for people with a sleep disorder who are at higher risk of developing Parkinson’s has recruited its first UK participant from the Discovery Cohort study at the Oxford Parkinson’s Disease Centre (OPDC)

Celebrations, reflections and catalysing the future of health: Professor Sir Aziz Sheikh’s inaugural lecture

Professor Sir Aziz Sheikh OBE gave his inaugural lecture at the University of Oxford, sharing his vision for transforming global health care through data, innovation and equity.

New screening method finds novel approaches to combat antimicrobial resistant bacteria

Scientists from the Ineos Oxford Institute for antimicrobial research (IOI) have developed a new screening method to tackle bacterial resistance to the tetracycline class of antibiotics. The results from this method provide the starting point to develop new drugs to treat drug-resistant infections. The findings have been published in Chemical Science.

Four Oxford researchers elected to the US National Academy of Science

Last week, the National Academy of Sciences in the US announced the election of 120 members and 30 international members in recognition of their distinguished and continuing achievements in original research. Election to membership in the NAS is a mark of excellence in science and considered one of the highest honours that a scientist can receive.

T-cell Receptors (TCR) drive Chimeric Antigen Receptors (CAR)

Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer treatments. This study, published in Cell, demonstrates that engineering T-cells to express both a Chimeric Antigen Receptor (CAR) and a T-cell Receptor (TCR) can improve their ability to distinguish between cancerous and healthy tissues—addressing a major challenge in current immunotherapy.

Latin-American genetic data available securely to approved researchers worldwide

Genetic data from the largest blood-based prospective study of a Latin-American population are now available securely to academic researchers worldwide through the DNAnexus Trusted Research Environment (TRE).

Lowering levels of Lipoprotein(a) could reduce the risk of heart attack and some types of stroke

Researchers at Oxford Population Health studying genetic variants that control levels of Lipoprotein(a), or Lp(a) discovered that lowering Lp(a) could reduce the risk of heart attack and large artery stroke in both East Asians and Europeans. The study is published in Circulation.

RDM researchers edit new edition of seminal haematology textbook

Professor Adam Mead is Editor-in-Chief and Graham Collins and Deborah Hay two of the editors for the eighth edition of this key reference work, now in its sixth decade.

New guidelines published for monitoring IBD patients to prevent bowel cancer

Researchers and clinicians have developed major new guidelines for the monitoring of patients with inflammatory bowel disease (IBD) to prevent them going on to develop bowel cancer.

Load More